NexgenRx Management
Management criteria checks 3/4
NexgenRx's CEO is Ron Loucks, appointed in Mar 2003, has a tenure of 21.67 years. total yearly compensation is CA$313.34K, comprised of 75% salary and 25% bonuses, including company stock and options. directly owns 10.48% of the company’s shares, worth $1.56M. The average tenure of the management team and the board of directors is 5.5 years and 12.5 years respectively.
Key information
Ron Loucks
Chief executive officer
CA$313.3k
Total compensation
| CEO salary percentage | 75.0% |
| CEO tenure | 21.7yrs |
| CEO ownership | 10.5% |
| Management average tenure | 5.5yrs |
| Board average tenure | 12.5yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -CA$25k |
| Mar 31 2024 | n/a | n/a | -CA$66k |
| Dec 31 2023 | CA$313k | CA$235k | -CA$332k |
| Sep 30 2023 | n/a | n/a | -CA$310k |
| Jun 30 2023 | n/a | n/a | -CA$244k |
| Mar 31 2023 | n/a | n/a | -CA$172k |
| Dec 31 2022 | CA$287k | CA$235k | -CA$22k |
| Sep 30 2022 | n/a | n/a | CA$3m |
| Jun 30 2022 | n/a | n/a | CA$4m |
| Mar 31 2022 | n/a | n/a | CA$4m |
| Dec 31 2021 | CA$230k | CA$215k | CA$4m |
| Sep 30 2021 | n/a | n/a | CA$2m |
| Jun 30 2021 | n/a | n/a | CA$2m |
| Mar 31 2021 | n/a | n/a | CA$2m |
| Dec 31 2020 | CA$153k | CA$140k | CA$2m |
| Sep 30 2020 | n/a | n/a | CA$1m |
| Jun 30 2020 | n/a | n/a | CA$483k |
| Mar 31 2020 | n/a | n/a | -CA$31k |
| Dec 31 2019 | CA$181k | CA$165k | -CA$208k |
| Sep 30 2019 | n/a | n/a | CA$38k |
| Jun 30 2019 | n/a | n/a | -CA$147k |
| Mar 31 2019 | n/a | n/a | -CA$438k |
| Dec 31 2018 | CA$181k | CA$165k | -CA$697k |
| Sep 30 2018 | n/a | n/a | -CA$1m |
| Jun 30 2018 | n/a | n/a | -CA$1m |
| Mar 31 2018 | n/a | n/a | -CA$793k |
| Dec 31 2017 | CA$181k | CA$165k | -CA$626k |
Compensation vs Market: Ron's total compensation ($USD222.40K) is below average for companies of similar size in the US market ($USD651.40K).
Compensation vs Earnings: Ron's compensation has increased whilst the company is unprofitable.
CEO
Ron Loucks (74 yo)
21.7yrs
Tenure
CA$313,342
Compensation
Mr. Ronald C. Loucks, also known as Ron, B.B.A. Founded NexgenRx, Inc. in March 2003 and has been its Chief Executive Officer and President since March 2003. Mr. Loucks has over 25 years of experience in t...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 21.7yrs | CA$313.34k | 10.48% $ 1.6m | |
| Chief Financial Officer | 7.5yrs | CA$60.00k | 0.63% $ 94.0k | |
| Vice President of Operations | less than a year | CA$169.40k | no data | |
| Vice President of Administration | no data | no data | no data | |
| Lead Human Resources | no data | no data | no data | |
| Company Secretary | 3.4yrs | no data | no data | |
| Financial Controller | no data | no data | no data |
5.5yrs
Average Tenure
Experienced Management: NEGX.F's management team is seasoned and experienced (5.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 21.7yrs | CA$313.34k | 10.48% $ 1.6m | |
| Independent Chairman | 18.7yrs | CA$30.00k | 0.88% $ 130.9k | |
| Director | less than a year | no data | no data | |
| Independent Director | 6.3yrs | CA$20.00k | 0.14% $ 20.9k |
12.5yrs
Average Tenure
74yo
Average Age
Experienced Board: NEGX.F's board of directors are seasoned and experienced ( 12.5 years average tenure).